Aemetis (NASDAQ:AMTX – Get Rating) announced its quarterly earnings results on Thursday. The specialty chemicals company reported ($0.03) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.44) by $0.41, Fidelity Earnings reports. During the same period in the prior year, the business posted ($0.38) earnings per share.
Aemetis Stock Up 24.8 %
AMTX stock opened at $10.18 on Friday. Aemetis has a twelve month low of $4.45 and a twelve month high of $23.33. The stock’s 50 day moving average is $6.33 and its 200-day moving average is $9.05. The firm has a market capitalization of $352.02 million, a PE ratio of -9.01 and a beta of 0.62.
Wall Street Analysts Forecast Growth
Several brokerages have issued reports on AMTX. Ascendiant Capital Markets lowered Aemetis to an “outperform” rating and set a $33.00 price target on the stock. in a report on Monday, June 6th. Credit Suisse Group cut their price target on Aemetis from $35.00 to $27.00 and set an “outperform” rating on the stock in a report on Monday, June 13th. One equities research analyst has rated the stock with a sell rating and four have issued a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $31.00.
Institutional Inflows and Outflows
Aemetis, Inc operates as a renewable natural gas and renewable fuels company in North America and India. It operates through three segments: California Ethanol, Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the acquisition, development, and commercialization of negative carbon intensity products and technologies that replace traditional petroleum-based products.
- Get a free copy of the StockNews.com research report on Aemetis (AMTX)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc’s Revenues Are Up, Is It Time to Buy?
- Why Apple Could Be At All-Time Highs By Year End
- Beyond Meat Is Not Beyond Hope, And It’s Cheap
Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.